JAGSNPHARMNSEJagsonpal Pharmaceuticals Limited· PharmaceuticalsMinimalNeutral
Announced Thu, 7 May · 15:49 IST

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.5%1-day move
₹214.30
prior close
₹211.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.0+1.6+1.4+3.7-2.5-1.1-1.8-3.6-3.9-8.3-5.7-7.8+6.8
Up moveDown movePending
AI summary

Jagsonpal Pharmaceuticals Limited has published a newspaper advertisement announcing the opening of its buyback offer. The company has already dispatched the Letter of Offer dated May 06, 2026 to all eligible shareholders holding equity shares as on the Record Date of May 04, 2026. The buyback window opens on May 08, 2026 and closes on May 14, 2026. Shareholders in the Reserved Category (Small Shareholders) and General Category will receive 47 equity shares for every 637 shares held, with entitlement factors of 7.38% and 7.38% respectively. The advertisement was published in Financial Express (English) and Jansatta (Hindi) across all editions.

Likely market impact

This buyback announcement indicates the company is returning capital to shareholders. The tender window runs from May 8-14, 2026, and eligible shareholders can participate by tendering their shares at the specified entitlement ratio.